A pharmaceutical firm with a strong focus on research and development, NATCO Pharma Ltd creates, produces, and markets sophisticated pharmaceuticals for specialised therapeutic markets.
NATCO has created a foothold in all three business sectors, namely contract manufacturing, active pharmaceutical ingredients, and completed dosage formulations.
Financial Results:
The company reported a net profit of ₹62.3 crore, down 22.5% as against ₹80.4 crore year-on-year. Revenue came in at ₹492.5 crore, down 12.1% as compared to ₹560.5 crore YoY.
Management Commentary:
“So I think Q4 and Q1 will — is our expectation and most of the profit share will be booked. We’ll — we already shipped the quantify for our Q1. So I think — so we’ll have a very good Q1 and Q4, and we’ll have a very good year. So our expectation is that, this year, I think we should — overall as a company, I think we should do about INR2,700 crores to INR2,800 crores in top line, and this year PAT also should be, I think, closer to INR700 crores this year. I think that’s our expectation. Probably our highest revenue and highest PAT in the history of the company.”
– Rajeev Nannapaneni, Chief Executive Officer
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,